Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
Novo Nordisk said it now offers cash-paying U.S. patients its blockbuster diabetes treatment Ozempic for less than half its monthly list price through multiple platforms. Patients can pay $499 in cash ...
Novo Nordisk is partnering with Costco to offer its members Wegovy and Ozempic for about half the price when customers pay out of pocket. NBC’s Anne Thompson reports for TODAY.Oct. 3, 2025 ...
Aug 18 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying patients with type 2 diabetes in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results